Predictive value of clinical judgment of tumour progression in phase II trials.

<h4>Background</h4>The diagnosis of tumour progression or progressive disease (PD) is a key element for designing and interpreting contemporary phase II trials. In some cases, PD is stated by the physician and is not formally confirmed by imaging.<h4>Purpose</h4>In this study...

Full description

Saved in:
Bibliographic Details
Main Authors: Nuria Kotecki, Nicolas Penel, Antoine Adenis, Charles Ferte, Stéphanie Clisant
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2012
Subjects:
R
Q
Online Access:https://doaj.org/article/3863f9b65184415893c32d5361af0b0c
Tags: Add Tag
No Tags, Be the first to tag this record!